Novartis Pharmaceuticals Corp., Translational Sciences, East Hanover, New Jersey, USA.
Compr Physiol. 2011 Oct;1(4):1795-835. doi: 10.1002/cphy.c100084.
Organic anions and cations (OAs and OCs, respectively) comprise an extraordinarily diverse array of compounds of physiological, pharmacological, and toxicological importance. The kidney, primarily the renal proximal tubule, plays a critical role in regulating the plasma concentrations of these organic electrolytes and in clearing the body of potentially toxic xenobiotics agents, a process that involves active, transepithelial secretion. This transepithelial transport involves separate entry and exit steps at the basolateral and luminal aspects of renal tubular cells. Basolateral and luminal OA and OC transport reflects the concerted activity of a suite of separate proteins arranged in parallel in each pole of proximal tubule cells. The cloning of multiple members of several distinct transport families, the subsequent characterization of their activity, and their subcellular localization within distinct regions of the kidney, now allows the development of models describing the molecular basis of the renal secretion of OAs and OCs. New information on naturally occurring genetic variation of many of these processes provides insight into the basis of observed variability of drug efficacy and unwanted drug-drug interactions in human populations. The present review examines recent work on these issues.
有机阴离子和阳离子(分别为 OAs 和 OCs)构成了具有生理、药理和毒理重要性的极其多样化的化合物。肾脏,主要是肾近端小管,在调节这些有机电解质的血浆浓度以及清除体内潜在毒性的外来物质方面起着关键作用,这一过程涉及主动的、跨上皮分泌。这种跨上皮转运涉及到肾管状细胞基底外侧和腔侧的单独进入和退出步骤。基底外侧和腔侧的 OA 和 OC 转运反映了在近端肾小管细胞每极平行排列的一系列单独蛋白的协同活性。对多个不同转运家族的多个成员的克隆、随后对其活性的表征以及它们在肾脏不同区域的细胞内定位,现在使得描述肾脏 OA 和 OC 分泌的分子基础的模型得以发展。关于许多这些过程中自然发生的遗传变异的新信息提供了对观察到的人类群体中药物疗效和不想要的药物相互作用变异性的基础的深入了解。本综述检查了这些问题的最新工作。